MONEY

Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 23, 2024 - 16:00
Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects
Read More

Tags:

Previous Article

Morgan Stanley bullish on Structure Therapeutics stock ahead of key obesity trial

Next Article

BofA sees earnings risk for Zegna stock amid weaker global luxury demand

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Toll Brothers Announces New 55+ Active-Adult Community at The Pinehills in Plymouth, Massachusetts

Toll Brothers Announces New 55+ Active-Adult Community ...

Tomas Kauer - Mode... Sep 13, 2024

Guidewire stock soars to all-time high of $176.03

Guidewire stock soars to all-time high of $176.03

Tomas Kauer - Mode... Sep 25, 2024

Mizuho raises Welltower stock target, maintains buy rating

Mizuho raises Welltower stock target, maintains buy rating

Tomas Kauer - Mode... May 9, 2024